Radiopharm Theranostics Ltd (RAD) - Cash Flow Conversion Efficiency

Latest as of June 2026: -1.349x

Based on the latest financial reports, Radiopharm Theranostics Ltd (RAD) has a cash flow conversion efficiency ratio of -1.349x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-30.11 Million ≈ $-21.31 Million USD) by net assets (AU$22.32 Million ≈ $15.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Radiopharm Theranostics Ltd worth for the company's overall valuation and market capitalisation.

Radiopharm Theranostics Ltd - Cash Flow Conversion Efficiency Trend (2021–2026)

This chart illustrates how Radiopharm Theranostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Radiopharm Theranostics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Radiopharm Theranostics Ltd ranked by their cash flow conversion efficiency. See RAD debt coverage from operations to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Spinnova Oy HE:SPINN	-0.081x
Bürgerliches Brauhaus Ravensburg - Lindau Aktiengesellschaft STU:BBR	N/A
Woojin Plaimm KO:049800	0.110x
Bliss Properti Indonesia Tbk PT JK:POSA	-0.004x
Carmit TA:CRMT	0.031x
D P Wires Limited NSE:DPWIRES	0.208x
Panagene Inc KQ:046210	0.001x
Live Ventures Inc NASDAQ:LIVE	0.103x

Annual Cash Flow Conversion Efficiency for Radiopharm Theranostics Ltd (2021–2026)

The table below shows the annual cash flow conversion efficiency of Radiopharm Theranostics Ltd from 2021 to 2026. View RAD share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-06-30	AU$22.32 Million ≈ $15.80 Million	AU$-52.78 Million ≈ $-37.35 Million	-2.364x	-176.62%
2025-06-30	AU$42.87 Million ≈ $30.33 Million	AU$-36.65 Million ≈ $-25.93 Million	-0.855x	-1.76%
2024-06-30	AU$27.35 Million ≈ $19.35 Million	AU$-22.98 Million ≈ $-16.26 Million	-0.840x	-65.01%
2023-06-30	AU$45.58 Million ≈ $32.25 Million	AU$-23.20 Million ≈ $-16.42 Million	-0.509x	-223.52%
2022-06-30	AU$62.96 Million ≈ $44.55 Million	AU$-9.91 Million ≈ $-7.01 Million	-0.157x	-159.62%
2021-06-30	AU$-124.70K ≈ $-88.24K	AU$-32.91K ≈ $-23.29K	0.264x	--

About Radiopharm Theranostics Ltd

AU:RAD Australia Biotechnology

Market Cap

$24.55 Million

AU$34.70 Million AUD

Market Cap Rank

#24541 Global

#996 in Australia

Share Price

AU$0.01

Change (1 day)

+14.29%

52-Week Range

AU$0.01 - AU$0.04

All Time High

AU$0.37